8-K ·Filed Apr 16, 2026

PROF

Profound Medical Corp.
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago SEC0001171843-26-002497
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

Traders should monitor the May 7 earnings release and call for updates on revenue, operating performance, and guidance. Until then, no new financial or strategic information is available.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
PROF ▲ +8.01% at T+60d
NEUTRAL call ✓ call won +8.01% · α vs SPY +0.96% · entry $6.62 → $7.15
Entry anchored
Apr 15, 03:59 PM ET
via exchange tick
T+1d
+0.45%
call +0.45% · α -0.76%
$6.65
settled 6mo ago
T+5d
+1.96%
call +1.96% · α +0.98%
$6.75
settled 5mo ago
T+20d
+7.25%
call +7.25% · α +1.44%
$7.10
settled 5mo ago
T+60d
+8.01%
call +8.01% · α +0.96%
$7.15
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Profound Medical Corp. announced it will release its first quarter 2026 financial results on May 7, 2026, after market close, followed by a conference call at 4:30 p.m. ET to review the results and discuss business developments. No financial data or guidance was provided in this filing.

Key Facts

  • Profound Medical will release Q1 2026 financial results on May 7, 2026, after market close.
  • Management will host a conference call on May 7, 2026, at 4:30 p.m. ET to discuss results and business developments.
  • No financial results, guidance, or material updates were disclosed in this filing.

Financial Impact

None disclosed — this filing only announces the upcoming earnings release and conference call.

Risk Factors

  • Market volatility may occur ahead of the May 7 earnings release due to lack of forward-looking statements in this filing.
  • No indication of performance direction (positive or negative) was provided, increasing uncertainty.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001171843-26-002497
Exhibit: exh_991.htm0001171843-26-002497
Document: 0001171843-26-002497-index-headers.html0001171843-26-002497
Document: 0001171843-26-002497-index.html0001171843-26-002497
Document: 0001171843-26-002497.txt0001171843-26-002497
13 reports for PROF
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PROF — sortable, filterable
TypeNow
Sep 4, 2026
28d ago
8-K
NEUTRAL ★ 2/10
$6.89 $5.81▼ −15.67%▼ −14.47%$5.85 (−15.09%)
Sep 3, 2026
29d ago
8-K
NEUTRAL ★ 3/10
$6.80 $5.97▼ −12.21%▼ −11.06%$5.85 (−13.97%)
Aug 17, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$6.55 $6.80▲ +3.82%▲ +5.01%$5.85 (−10.69%)
Aug 17, 2026
6w ago
8-K
NEUTRAL ★ 2/10
$6.55 $6.80▲ +3.82%▲ +5.01%$5.85 (−10.69%)
Jul 24, 2026
10w ago
8-K
BULLISH ★ 6/10
$7.26 $7.25▼ −0.14%▼ −0.51%$5.85 (−19.42%)
Jul 15, 2026
11w ago
8-K
NEUTRAL ★ 2/10
$6.96 $6.99▲ +0.43%▲ +1.41%$5.85 (−15.95%)
May 14, 2026
20w ago
8-K
NEUTRAL ★ 3/10
$6.97 $6.83▼ −2.01%▼ −2.97%$5.85 (−16.07%)
May 12, 2026
20w ago
S-3
NEUTRAL ★ 3/10
$7.10 $6.73▼ −5.21%▼ −4.05%$5.85 (−17.61%)
Apr 16, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$6.62 $6.75▲ +1.96%▲ +0.98%$5.85 (−11.63%)
Apr 14, 2026
24w ago
8-K
NEUTRAL ★ 3/10
$6.26 $6.84▲ +9.27%▲ +7.87%$5.85 (−6.55%)
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (37h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access